OKUR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Onkure Therapeutics Inc (OKUR) is not a strong buy at the moment for a beginner investor with a long-term strategy. The lack of positive financial performance, absence of significant trading trends, and no recent news or catalysts make it a hold for now. The technical indicators show mixed signals, and there is no proprietary trading signal to support an immediate buy decision.
The MACD is below 0 and negatively contracting, indicating a weak momentum. RSI is neutral at 70.073, suggesting no overbought or oversold conditions. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), but the stock is trading near resistance levels (R1: 4.647). The stock has a 60% chance to move slightly up by 0.05% in the next day but shows a potential decline of -1.47% in the next week.
NULL identified. No recent news or significant trading trends from hedge funds or insiders.
Analysts have lowered the price target from $34 to $27 due to an anticipated equity raise in Q2.
In Q4 2025, revenue remained at 0 with no growth. Net income dropped significantly to -$13,503,000 (-61.63% YoY), and EPS fell to -0.99 (-89.42% YoY). Gross margin stayed at 0 with no improvement.
H.C. Wainwright maintains a Buy rating but lowered the price target from $34 to $27 due to an anticipated equity raise in Q2. This reflects a cautious outlook despite the Buy rating.
